Abstract Library

#3971 Clinical manifestation and aggressiveness of duodenopancreatic neuroendocrine tumors (DP-NET) in patients with MEN1 syndrome: A possible role of exon 2 mutations in menin gene

Introduction: Multiple endocrine neoplasia type 1 (MEN1) is a rare syndrome characterized by co-occurrence of primary hyperparathyroidism (PH), duodenopancreatic neuroendocrine tumors (DP-NET) and/or pituitary adenomas without an established genotype-phenotype correlation.

Conference:

Presenting Author: Benevento E

Authors: Benevento E, Liccardi A, Minotta R, Cannavale G, Di Iasi G,

Keywords: Multiple endocrine neoplasia type 1 (MEN1), exon two, genomic, primary hyperparathyroidism, duodenopancreatic neuroendocrine tumor, DP-NET, pituitary adenomas,

#1722 New MEN-1 Gene Mutation Implicated in Familiar MEN-1 Syndrome Onset

Introduction: Multiple endocrine neoplasia type 1 (MEN1) is a rare genetic syndrome associated with an increased risk of developing parathyroid, pituitary and pancreatic neuroendocrine tumors. MEN1 has an autosomal dominant pattern of hereditability and it is usually related to mutations in menin coding gene

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Grego E, Pellicciari M, Novak L, Ortolani S, Antista M,

Keywords: MEN1 syndrome, MEN1 gene mutation, neuroendocrine tumor,

#1027 Chromogranin A (CgA) in Pheochromocytoma and in Multiple Endocrine Neoplasia Type 1.

Introduction: Chromogranin A (CgA) as a main, nonspecific marker of neuroendocrine tumors (NET) has been applied for diagnostic purposes and for monitoring the treatment of NET. Pheochromocytoma and MEN-1 syndrome represent rare neuroendocrine tumours.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Glinicki P, Jeske W, Bednarek-Papierska L, Rosłonowska E, Zgliczyński W,

Keywords: chromogranin A, CgA, pheochromocytoma, multiple endocrine neoplasia, neuroendocrine tumors,

#774 The Grading of pNENs in MEN-1 Syndrome: Consequences for Tumor Progression and Surgical Strategy?

Introduction: MEN-1 patients develop multiple pNENs. The treatment of choice ranges from watchful waiting to total pancreatectomy. Up to now, the impact of the grading has not been evaluated to either plan surgery or conservative treatment.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: Selberherr A

Authors: Selberherr A, Koperek O, Niederle B,

Keywords: MEN-1, pancreas, pNEN,

#716 Adrenal Metastases and Neuroendocrine Breast Carcinoma in a MEN-1 Patient

Introduction: In Multiple Endocrine Neoplasia type 1 (MEN-1) pituitary, parathyroid and pancreatic/duodenal endocrine cells are typically involved. Other neoplasms also occur.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: Pasquali C

Authors: Moletta L, Milanetto A, Sperti C, Alaggio R, Pedrazzoli S,

Keywords: MEN-1 syndrome, breast cancer, adrenal metastasis, rare tumors,